Form 8-K - Current report:
SEC Accession No. 0001193125-24-163397
Filing Date
2024-06-18
Accepted
2024-06-18 16:07:03
Documents
13
Period of Report
2024-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d852980d8k.htm   iXBRL 8-K 36047
  Complete submission text file 0001193125-24-163397.txt   155075

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA advm-20240617.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20240617_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20240617_pre.xml EX-101.PRE 10812
17 EXTRACTED XBRL INSTANCE DOCUMENT d852980d8k_htm.xml XML 3516
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 241051742
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)